Skip to main content

Table 5 Comparison of the Levels of 80 Soluble Factors in Heat Inactivated Serum and Heat Inactivated Recalcified Plasma

From: Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion

Factor

Heat Inactivated Serum

Heat Inactivated Recalcified Plasma

P*

ACRP-30 (microg/mL)

15.9 ± 10.5

9.0 ± 5.8

0.000209

Amphiregulin (pg/mL)

7 ± 11

3 ± 5

N.S.

ANG-2 (pg/mL)

0 ± 0

0 ± 0

N.S.

Apo A-1 (microg/mL)

89.0 ± 16.6

70.0 ± 17.3

0.000433

ApoB-100 (microg/mL)

637 ± 147

544 ± 98

0.00831

A-SAA (microg/mL)

14.7 ± 4.80

11.4 ± 4.12

0.00228

BDNF (ng/mL)

7.23 ± 3.04

4.17 ± 1.54

N.S.

CD14 (pg/mL)

998 ± 2,439

9,922 ± 11,223

N.S.

CD40L (pg/mL)

48 ± 81

70 ± 63

N.S.

CNTF (pg/mL)

0 ± 0

0 ± 0

N.S.

CRP (microg/mL)

3.52 ± 0.84

2.33 ± 4.71

N.S.

ENA-78 (pg/mL)

637 ± 392

343 ± 122

N.S.

Eotaxin (pg/mL)

16 ± 26

25 ± 14

N.S.

Eotaxin2 (ng/mL)

1.66 ± 1.24

3.13 ± 2.33

0.000712

E-Selectin (ng/mL)

73.1 ± 16.7

70.0 ± 15.0

N.S.

Exodus 2 (pg/mL)

53 ± 21

106 ± 55

0.00976

FGF Basic (pg/mL)

218 ± 175

160 ± 219

N.S.

Fibrinogen (ng/mL)

174 ± 44.2

217 ± 76.7

N.S.

G-CSF (pg/mL)

29 ± 22

41 ± 19

N.S.

GM-CSF (pg/mL)

555 ± 267

623 ± 311

N.S.

GRO-alpha (pg/mL)

67 ± 61

36 ± 12

N.S.

HGF (pg/mL)

206 ± 124

224 ± 43

N.S.

HGH (pg/mL)

164 ± 148

159 ± 159

N.S.

I-309 (pg/mL)

27 ± 64

21 ± 38

N.S.

ICAM-1 (ng/mL)

145 ± 44.3

183 ± 48.7

0.00518

IFN-α (pg/mL)

1 ± 1.3

0.8 ± 1.3

N.S.

IFN-γ (pg/mL)

3 ± 9

3 ± 9

N.S.

IL-11 (pg/mL)

0 ± 0

0 ± 0

N.S.

IL-12p40 (pg/mL)

7 ± 15

6 ± 10

N.S.

IL-16 (pg/mL)

62 ± 19

66 ± 21

N.S.

IL-1α (pg/mL)

12 ± 26

11 ± 25

N.S.

IL-1Ra (pg/mL)

183 ± 328

150 ± 283

N.S.

IL-2 (pg/mL)

22 ± 32

21 ± 27

N.S.

IL-2R (ng/mL)

1.21 ± 0.67

1.49 ± 0.78

N.S.

IL-2Rγ (pg/mL)

0 ± 0

0 ± 0

N.S.

IL-6 (pg/mL)

7 ± 13

7 ± 12

N.S.

IL-6R (pg/mL)

30 ± 13

40 ± 10

0.00451

IL-7 (pg/mL)

5 ± 6

0.9 ± 2.6

N.S.

IL-8 (pg/mL)

7 ± 7

6 ± 9

N.S.

IL-9 (pg/mL)

771 ± 1,457

608 ± 1,259

N.S.

IP-10 (pg/mL)

128 ± 77

141 ± 55

N.S.

ITAC (pg/mL)

8 ± 10

8 ± 6

N.S.

KGF (pg/mL)

34 ± 17

26 ± 12

N.S.

LEPTIN (ng/mL)

2.15 ± 3.04

2.56 ± 3.06

N.S.

L-Selectin (microg/mL)

1.16 ± 0.32

1.06 ± 0.26

N.S.

Lymphotactin (pg/mL)

94 ± 107

86 ± 94

N.S.

MCP-1 (pg/mL)

456 ± 187

514 ± 153

N.S.

MCP-2 (pg/mL)

55 ± 15

47 ± 18

N.S.

MCP-3 (pg/mL)

0 ± 0

0 ± 0

N.S.

MCP-4 (pg/mL)

27 ± 19

30 ± 14

N.S.

MDC (pg/mL)

504 ± 127

463 ± 92

N.S.

MIG (pg/mL)

113 ± 61

119 ± 59

N.S.

MIP-1α (pg/mL)

60 ± 22

43 ± 32

N.S.

MIP-1β (pg/mL)

61 ± 35

69 ± 37

N.S.

MIP-3α (pg/mL)

6 ± 1

7 ± 2

N.S.

MIP-3β (pg/mL)

37 ± 13

56 ± 15

0.00714

MMP-1 (ng/mL)

3.17 ± 2.19

0.68 ± 0.46

0.00612

MMP-10 (pg/mL)

34 ± 45

0 ± 0

N.S.

MMP-13 (pg/mL)

60 ± 114

0 ± 0

N.S.

MMP-2 (ng/mL)

205 ± 35.7

125 ± 31.2

1.09 × 10 -05

MMP-3 (ng/mL)

5.58 ± 2.99

1.44 ± 0.92

5.09 × 10-07

MMP-9 (ng/mL)

48.0 ± 35.6

15.4 ± 9.2

0.00217

MPIF-1 (pg/mL)

599 ± 184

616 ± 199

N.S.

MPO (ng/mL)

45.8 ± 13.6

32.0 ± 6.3

0.00206

NAP-2 (microg/mL)

2.80 ± 2.03

0.21 ± 0.20

8.47 × 10 -05

NT3 (pg/mL)

10 ± 9

5 ± 8

N.S.

OPG (pg/mL)

3 ± 2

7 ± 4

0.00276

OPN (ng/mL)

2.13 ± 1.50

2.91 ± 2.68

N.S.

PAI-1 Active (pg/mL)

211 ± 179

97 ± 93

N.S.

PAI-1 Total (ng/mL)

4.33 ± 2.72

1.67 ± 1.54

0.00585

PDGF-BB (pg/mL)

165 ± 171

85 ± 198

N.S.

RANTES (ng/mL)

10.8 ± 12.2

3.9 ± 1.5

N.S.

SDF-1β (pg/mL)

173 ± 156

237 ± 172

N.S.

TARC (pg/mL)

74 ± 41

39 ± 10

N.S.

TIMP-1 (ng/mL)

121 ± 56.4

82.3 ± 17.1

N.S.

TIMP-2 (ng/mL)

109 ± 25.8

94.0 ± 16.2

N.S.

TNF-α (pg/mL)

46 ± 35

48 ± 38

N.S.

TNF-RI (pg/mL)

433 ± 115

413 ± 111

N.S.

TNF-R2 (pg/mL)

150 ± 46

584 ± 136

6.63 × 10-07

VCAM-1 (ng/mL)

46.5 ± 13.6

69.1 ± 12.0

0.000540

  1. N.S. = Not Significant
  2. *p values were calculated using Student's paired T tests and natural log transformed data.
  3. Values are mean ± one standard deviation.